Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Vues
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé